Terpenoid Therapeutics, Inc. is a drug discovery and development company focused on cancer. The company uses the platform of terpene chemistry to develop candidate drug molecules. The firm is seeking to generate a robust pipeline of terpene-derived therapeutic agents. Terpenoid projects are built upon a fifteen-year academic collaboration of the Terpenoid founders who have expertise in the biology and chemistry of terpene metabolism, pharmacology and oncology. The company maintains active collaborations with the academic labs of the founders. Terpenoid currently has two projects to discover novel drugs. One project is focused on discovering small molecule inhibitors of geranylgeranyl diphosphate synthase, a novel target with applicability towards cancer and other indications. Another project is focused on the schweinfurthins, a family of novel cytotoxic agents with applicability towards cancer
